CongressBuys
Committee overlap: Finance

Sen. Mark R. Warner sold Amgen (AMGN)

Sen. Mark R. Warner (D-VA) · $1K–$15K · traded Apr 7, 2026

Why this is a committee overlap

Warner is a member of the Senate Committee on Finance, which oversees Drug Manufacturers companies. Amgen is classified in the Drug Manufacturers - General industry.

An overlap is a fact about the trade, not evidence of wrongdoing. Committee assignments are current ones.

Transaction
Sold
Amount
$1K–$15K
Owner
Joint
Traded
Apr 7, 2026
Disclosed
May 1, 2026
Days to disclose
24
Asset type
Stock
As filed
Amgen Inc
Industry
Drug Manufacturers - General · Healthcare

Other trades in this filing

All of Warner's trades →

Recent Congress trades in AMGN

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.

Sen. Mark R. Warner sold Amgen (AMGN) | CongressBuys